查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301173

控释药物输送市场规模、份额和趋势分析报告：2023-2030 年按技术、释放机制、应用、地区、细分市场划分的趋势

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report, By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

控释给药市场的增长和趋势

据Grand View Research, Inc.最新报告显示，预计到2030年，全球控释给药市场规模将达到1101.3亿美元，复合年增长率为10.6%。

与控释药物输送系统相关的优势，例如提高治疗效果、减少副作用和降低治疗成本，是预测期内推动市场增长的因素。与传统的交付形式相比，这些技术具有多种优势。减少剂量和给药频率、增强患者依从性、减少胃肠道副作用、疗效均一化、提高功效和安全性以及减少血浆药物浓度的变异性是控释技术的主要优点和一些优点。

体内存在影响药物吸收、生物利用度和稳定性的多种生物屏障，为控释药物递送产品开闢了广阔的前景。例如，控释药物递送系统使得递送更大且复杂的分子成为可能，例如DNA/RNA、蛋白质和多□。此外，医疗保健专业人员对控释给药系统相对于传统系统的优越性的认识不断增强，预计从长远来看也将提振市场需求。

老年人和儿童人口的增加是影响市场增长的主要因素之一。这是因为在这个年龄组中，不提供处方的比例很高。各种药物输送系统创新为老年人和儿科人群提供了简单的解决方案，进一步推动了市场的发展。药物的控释可以根据特定时间段内所需的剂量而变化，从而减少老年人群的药物过量。

控释药物输送市场报告亮点

  • 从应用来看，由于使用量的增加和给药的便利性，口服控释系统将在 2022 年占据最大的市场份额。
  • 靶向药物递送由于具有提高治疗效果和提高安全性等多种优势，预计将成为预测期内增长最快的技术领域。
  • 基于激活调节药物递送系统的渗透递送领域预计将出现最高的复合年增长率，因为它不受pH、食物摄入和胃肠道蠕动等各种因素的影响。

目录

第一章 调查方法和范围

  • 市场细分和范围
  • 调查方法
  • 信息采购
  • 信息或数据分析
  • 市场形成和验证
  • 型号详情
  • 二级信息列表
  • 主要信息列表
  • 目的

第二章执行摘要

  • 市场展望
  • 分部展望
  • 竞争考虑

3.控释给药市场变量、趋势和范围

  • 市场谱系展望
    • 母公司市场展望
    • 相关/辅助市场展望
  • 采用和增长前景图
  • 行业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动力分析
    • 市场约束因素分析
  • 控释药物输送市场分析工具
    • 行业分析-波特分析
    • PESTEL 分析
    • 主要交易和战略联盟分析
    • 市场进入策略

第四章全球控释给药市场：技术评估与趋势分析

  • 定义和范围
  • 2022 年和 2030 年控释给药市场份额
  • 细分仪表板
  • 按技术划分：全球控释给药市场展望
  • 2018-2030年以下市场规模、预测和趋势分析
    • 厄斯特技术
    • 凝聚
    • 微胶囊化
    • 注入
    • 透皮
    • 定向投放
    • 其他（微机电技术、脂质体）

第五章全球控释给药市场：释放机制估计及趋势分析

  • 定义和范围
  • 2022 年和 2030 年控释给药市场份额
  • 细分仪表板
  • 按释放机制：全球控释给药市场展望
  • 2018-2030年以下市场规模、预测和趋势分析
    • 聚合物基系统
    • 微储库分区控制给药系统
    • 反馈调节药物输送系统
    • 激活控制的药物输送系统
    • 化学活化

第六章全球控释给药市场：应用估算和趋势分析

  • 定义和范围
  • 2022 年和 2030 年控释给药市场份额
  • 细分仪表板
  • 按应用分类：全球控释给药市场展望
  • 2018-2030年以下市场规模、预测和趋势分析
    • 定量吸入器
    • 可注射的
    • 透皮贴剂和眼贴剂
    • 输液泵
    • 口服控释给药系统
    • 药物洗脱支架

第七章全球控释给药市场：区域估计与趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场快照
  • 2022 年区域市场份额和主要参与者
  • SWOT 分析，按因素（政治/法律、经济/技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场规模、预测、数量和趋势分析：
  • 北美
    • 2018-2030 年市场估计和预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年市场估计和预测
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 俄罗斯
    • 瑞士
    • 荷兰
    • 瑞典
    • 比利时
    • 其他
  • 亚太地区
    • 2018-2030 年市场估计和预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 越南
    • 马来西亚
    • 新加坡
    • 其他
  • 拉丁美洲
    • 2018-2030 年市场估计和预测
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 其他
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特
    • 以色列
    • 其他

第8章 竞争格局

  • 主要市场进入者的最新发展和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 上市公司
  • 民营企业
    • 关键初创企业/技术颠覆者/创新者名单
    • 资金前景
    • 区域网络图
    • 公司市场分析（地理位置、产品组合、主要联盟、行业经验）
    • 供应商排名
    • 主要公司概况
    • Depomed, Inc.
    • Coating Place, Inc.
    • Corium International, Inc.
    • Johnson and Johnson Services, Inc.
    • Alkermes plc
    • Pfizer, Inc.
    • Orbis Biosciences, Inc.
    • Capsugel
    • Merck and Co., Inc.
    • Aradigm Corporation
Product Code: GVR-2-68038-347-8

Controlled Release Drug Delivery Market Growth & Trends

The global controlled release drug delivery market size is expected to reach USD 110.13 billion by 2030, registering a CAGR of 10.6% according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology.

The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.

Controlled Release Drug Delivery Market Report Highlights

  • Based on application, oral controlled release systems held the largest share in the market in 2022 owing to increasing usage and ease of convenience offered for the administration of medication
  • Targeted drug delivery is poised to be the fastest-growing technology segment during the forecast period owing to its various benefits such as increased therapeutic efficacy coupled with increased safety
  • The osmotic delivery segment, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Release mechanism
    • 1.1.3. Application
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Release mechanism outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. controlled release drug delivery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
      • 3.4.1.2. Increased compliance due to nature of dosage forms
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
      • 3.4.2.2. Need for high dose of active pharmaceutical ingredient
  • 3.5. controlled release drug delivery Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Wurster technique
    • 4.1.2. Coacervation
    • 4.1.3. Micro encapsulation
    • 4.1.4. Implants
    • 4.1.5. Transdermal
    • 4.1.6. Targeted delivery
    • 4.1.7. Others (microelectromechanical technology, liposomes)
  • 4.2. Controlled release drug delivery Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global controlled release drug delivery Market by Technology Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Wurster technique
      • 4.5.1.1. Wurster technique controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.2. Coacervation
      • 4.5.2.1. Coacervation controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.3. Micro Encapsulation
      • 4.5.3.1. Micro encapsulation controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.4. Implants
      • 4.5.4.1. Implants controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.5. Transdermal
      • 4.5.5.1. Transdermal controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.6. Targeted delivery
      • 4.5.6.1. Targeted delivery controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.7. Others (microelectromechanical technology, liposomes)
      • 4.5.7.1. Others controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Polymer Based Systems
    • 5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
    • 5.1.3. Feedback Regulated Drug Delivery Systems
    • 5.1.4. Activation-modulated Drug Delivery Systems
      • 5.1.4.1. Osmotic Pressure Activated
      • 5.1.4.2. Hydrodynamic Pressure Activated
      • 5.1.4.3. Vapor Pressure Activated
      • 5.1.4.4. Mechanically Activated
      • 5.1.4.5. Magnetically Activated
    • 5.1.5. Chemically Activated
      • 5.1.5.1. pH Activated
      • 5.1.5.2. Hydrolysis Activated
      • 5.1.5.3. Enzyme Activated
  • 5.2. Controlled release drug delivery Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Polymer based systems
      • 5.5.1.1. Polymer based systems controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 5.5.2. Micro reservoir partition controlled drug delivery systems
      • 5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2018 - 2030 (USD Million)
    • 5.5.3. Feedback regulated drug delivery systems
      • 5.5.3.1. Feedback regulated drug delivery systems market, 2018 - 2030 (USD Million)
    • 5.5.4. Activation-modulated drug delivery systems
      • 5.5.4.1. Activation-modulated drug delivery systems market, 2018 - 2030 (USD Million)
      • 5.5.4.2. Osmotic pressure activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.3. Hydrodynamic pressure activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.4. Vapor pressure activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.5. Mechanically activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.6. Magnetically activated systems market, 2018 - 2030 (USD Million)
    • 5.5.5. Chemically activated
      • 5.5.5.1. pH activated controlled release drug delivery market, 2018 - 2030 (USD Million)
      • 5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2018 - 2030 (USD Million)
      • 5.5.5.3. Enzyme activated controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Metered Dose Inhalers
    • 6.1.2. Injectable
    • 6.1.3. Transdermal and Ocular Patches
    • 6.1.4. Infusion Pumps
    • 6.1.5. Oral Controlled-drug delivery Systems
    • 6.1.6. Drug Eluting Stents
  • 6.2. controlled release drug delivery Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global controlled release drug delivery Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Metered dose inhalers
      • 6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.2. Injectable
      • 6.5.2.1. Injectable controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.3. Transdermal and ocular patches
      • 6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.4. Infusion Pumps
      • 6.5.4.1. Infusion pumps controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.5. Oral controlled release drug delivery system
      • 6.5.5.1. Oral controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.6. Drug eluting stents
      • 6.5.6.1. Drug eluting stents controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2022
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. UK
      • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.4. France
      • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.7. Russia
      • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.8. Switzerland
      • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.9. The Netherland
      • 7.8.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.10. Sweden
      • 7.8.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.11. Belgium
      • 7.8.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.12. Others
      • 7.8.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. China
      • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. India
      • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.5. South Korea
      • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.6. Thailand
      • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.7. Indonesia
      • 7.9.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.8. Philippines
      • 7.9.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.9. Vietnam
      • 7.9.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.10. Malaysia
      • 7.9.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.11. Singapore
      • 7.9.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.12. Others
      • 7.9.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.3. Mexico
      • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.4. Argentina
      • 7.10.4.7. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.5. Colombia
      • 7.10.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.6. Chile
      • 7.10.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.7. Others
      • 7.10.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11. MEA
    • 7.11.1. South Africa
      • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.3. UAE
      • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.4. Kuwait
      • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.5. Israel
      • 7.11.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.6. Others
      • 7.11.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
    • 8.2.2. Market Leaders
    • 8.2.3. Emerging Players
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2022
  • 8.4. Public Companies
    • 8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 8.4.2. Company market share/ranking, by region
    • 8.4.3. Competitive dashboard analysis
      • 8.4.3.1. Market differentiators
      • 8.4.3.2. Synergy analysis: major deals and strategic alliances
  • 8.5. Private Companies
    • 8.5.1. List of key emerging company's/technology disruptors/innovators
    • 8.5.2. Funding outlook
    • 8.5.3. Regional network map
    • 8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
    • 8.5.5. Supplier ranking
    • 8.5.6. Key company profiled
    • 8.5.7. Depomed, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Coating Place, Inc.
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Corium International, Inc.
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Johnson and Johnson Services, Inc.
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic Initiative
    • 8.5.11. Alkermes plc
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Pfizer, Inc.
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Orbis Biosciences, Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Capsugel
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Merck and Co., Inc.
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Aradigm Corporation
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 5 North America controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 7 U.S. controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 8 U.S. controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Canada controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 11 Canada controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 15 Europe controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 16 Germany controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Germany controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 18 Germany controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.K. controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 20 U.K. controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 21 U.K. controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 22 France controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 24 France controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 25 Italy controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Italy controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 27 Italy controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 28 Spain controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Spain controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 30 Spain controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 31 The Netherland controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 32 The Netherland controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 33 The Netherland controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 34 Switzerland controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Switzerland controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 36 Switzerland controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 37 Russia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Russia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 39 Russia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 42 Sweden controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 43 Belgium controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Belgium controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 45 Belgium controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Japan controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 52 Japan controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 53 China controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 54 China controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 55 China controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 56 India controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 57 India controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 58 India controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 61 South Korea controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 62 Thailand controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Thailand controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 64 Thailand controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 65 Indonesia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Indonesia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 67 Indonesia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 68 Philippines controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Philippines controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 70 Philippines controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 71 Vietnam controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Vietnam controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 73 Vietnam controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 74 Singapore controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 75 Singapore controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 76 Singapore controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 77 Malaysia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Malaysia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 79 Malaysia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 80 Latin America controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 81 Latin America controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Latin America controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 83 Latin America controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 84 Brazil controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 85 Brazil controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 86 Brazil controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 87 Mexico controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Mexico controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 89 Mexico controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 90 Argentina controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 91 Argentina controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 92 Argentina controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 93 Colombia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 94 Colombia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 95 Colombia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 96 Chile controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Chile controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 98 Chile controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 99 Middle east and Africa controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 100 Middle east and Africa controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Middle east and Africa controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 102 Middle east and Africa controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 103 South Africa controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Africa controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 105 South Africa controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 109 UAE controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 110 UAE controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 111 UAE controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 112 Kuwait controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 113 Kuwait controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 114 Kuwait controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 115 Israel controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Israel controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 117 Israel controlled release drug delivery market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 controlled release drug delivery market: market outlook
  • Fig. 14 controlled release drug delivery market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 controlled release drug delivery market driver impact
  • Fig. 20 controlled release drug delivery market restraint impact
  • Fig. 21 controlled release drug delivery market strategic initiatives analysis
  • Fig. 22 controlled release drug delivery market: technology movement analysis
  • Fig. 23 controlled release drug delivery market: technology outlook and key takeaways
  • Fig. 24 Wurster technique market estimates and forecast, 2018 - 2030
  • Fig. 25 Coacervation market estimates and forecast, 2018 - 2030
  • Fig. 26 Micro encapsulation market estimates and forecast, 2018 - 2030
  • Fig. 27 Implants market estimates and forecast, 2018 - 2030
  • Fig. 28 Transdermal market estimates and forecast, 2018 - 2030
  • Fig. 29 Targeted delivery market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 controlled release drug delivery market: release mechanism movement analysis
  • Fig. 32 controlled release drug delivery market: release mechanism outlook and key takeaways
  • Fig. 33 Polymer based systems market estimates and forecast, 2018 - 2030
  • Fig. 34 Micro reservoir partition-controlled drug delivery systems estimate and forecasts, 2018 - 2030
  • Fig. 35 Feedback regulate drug delivery systems estimates and forecasts, 2018 - 2030
  • Fig. 36 Activation-modulated drug delivery systems estimates and forecasts, 2018 - 2030
  • Fig. 37 Chemically activated drug delivery systems estimates and forecasts, 2018 - 2030
  • Fig. 38 controlled release drug delivery market: application movement analysis
  • Fig. 39 controlled release drug delivery market: application outlook and key takeaways
  • Fig. 40 Metered dose inhaler market estimates and forecasts, 2018 - 2030
  • Fig. 41 Injectable controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 42 Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 43 Infusion pumps controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 44 Oral controlled drug delivery systems market estimates and forecasts, 2018 - 2030
  • Fig. 45 Drug eluting stents controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 46 Global controlled release drug delivery market: regional movement analysis
  • Fig. 47 Global controlled release drug delivery market: regional outlook and key takeaways
  • Fig. 48 Global controlled release drug delivery market shares and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 66 Europe
  • Fig. 67 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecasts, 2018 - 2030
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 78 Russia
  • Fig. 79 Russia market estimates and forecasts, 2018 - 2030
  • Fig. 80 The Netherlands
  • Fig. 81 The Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 82 Switzerland
  • Fig. 83 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 84 Sweden
  • Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 86 Belgium
  • Fig. 87 Belgium market estimates and forecasts, 2018 - 2030
  • Fig. 88 Asia Pacific
  • Fig. 89 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 90 China
  • Fig. 91 China market estimates and forecasts, 2018 - 2030
  • Fig. 92 Japan
  • Fig. 93 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 94 India
  • Fig. 95 India market estimates and forecasts, 2018 - 2030
  • Fig. 96 Thailand
  • Fig. 97 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 98 South Korea
  • Fig. 99 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 100 Indonesia
  • Fig. 101 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 102 Philippines
  • Fig. 103 Taiwan market estimates and forecasts, 2018 - 2030
  • Fig. 104 Vietnam
  • Fig. 105 Singapore market estimates and forecasts, 2018 - 2030
  • Fig. 106 Singapore
  • Fig. 107 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 108 Malaysia
  • Fig. 109 Malaysia market estimates and forecasts, 2018 - 2030
  • Fig. 110 Latin America
  • Fig. 111 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 112 Brazil
  • Fig. 113 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 114 Mexico
  • Fig. 115 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 116 Argentina
  • Fig. 117 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 118 Colombia
  • Fig. 119 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 120 Chile
  • Fig. 121 Chile market estimates and forecasts, 2018 - 2030
  • Fig. 122 Middle East and Africa
  • Fig. 123 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 124 South Africa
  • Fig. 125 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 126 Saudi Arabia
  • Fig. 127 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 128 UAE
  • Fig. 129 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 130 Kuwait
  • Fig. 131 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 132 Israel
  • Fig. 133 Israel market estimates and forecasts, 2018 - 2030
  • Fig. 134 Participant categorization- controlled release drug delivery market
  • Fig. 135 Market share of key market players- controlled release drug delivery market